Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Pharmaceuticals

    Tag: Pharmaceuticals

    You Searched For "Pharmaceuticals"
    AIOCD threatens to Boycott CIPLA if it enters into E-Pharmacy Business

    AIOCD threatens to Boycott CIPLA if it enters into E-Pharmacy Business

    Farhat Nasim31 Aug 2019 2:35 PM IST
    New Delhi: A lobby of 8.5 lakh chemists across the country is planning to boycott the products manufactured by Cipla if the company enters the e...
    Pfizer, GSK completes transaction to form new consumer healthcare JV

    Pfizer, GSK completes transaction to form new consumer healthcare JV

    Medical Dialogues Bureau3 Aug 2019 9:40 AM IST
    The Joint Venture brings together two highly complementary portfolios of trusted consumer health brands, including GSK's Sensodyne, Voltaren and...
    FIRST: Intas Pharma launches Romiplostim to treat chronic ITP in India

    FIRST: Intas Pharma launches Romiplostim to treat chronic ITP in India

    Medical Dialogues Bureau12 July 2019 11:48 AM IST
    Romiplostim is one of the most efficacious agents with proven long-term benefits in chronic ITP, a release here said.Mumbai: Pharma Major, Intas...
    Oklahoma judge denies motion to end case against drugmaker JnJ

    Oklahoma judge denies motion to end case against drugmaker JnJ

    Medical Dialogues Bureau9 July 2019 9:00 AM IST
    District Judge Thad Balkman denied Johnson & Johnson lawyers' motion asking him to end the case mid-trial and rule in favour of the New Brunswick,...
    Alembic Pharma gets USFDA nod for Bromfenac Ophthalmic Solution

    Alembic Pharma gets USFDA nod for Bromfenac Ophthalmic Solution

    Farhat Nasim24 Jun 2019 12:25 PM IST
    The approved product, Bromfenac Ophthalmic Solution is therapeutically equivalent to the reference listed drug (RLD), Bromday Ophthalmic Solution,...
    GSK eyes sale of $1.2 billion consumer health drugs; says report

    GSK eyes sale of $1.2 billion consumer health drugs; says report

    Medical Dialogues Bureau22 Jun 2019 8:59 AM IST
    GSK is streamlining its product offering as it prepares to fold its consumer business into a joint venture with Pfizer in the second half of this...
    GSK pharma head flags need for speed in high-pressure drug market

    GSK pharma head flags need for speed in high-pressure drug market

    Medical Dialogues Bureau18 Jun 2019 2:06 PM IST
    LONDON: Doing things one at a time in drug development is not a luxury that GlaxoSmithKline can afford any longer, the head of pharmaceuticals at...
    Novartis gets new pharma chief Marie-France Tschudin; bids farewell to Paul Hudson

    Novartis gets new pharma chief Marie-France Tschudin; bids farewell to Paul Hudson

    Farhat Nasim9 Jun 2019 9:25 AM IST
    Marie-France Tschudin succeeds Paul Hudson who will be leaving Novartis to take the CEO position of a multinational pharmaceuticals company.Basel:...
    GSK reintroduce incentives for sales representatives

    GSK reintroduce incentives for sales representatives

    Farhat Nasim24 May 2019 9:31 AM IST
    GSK said it would make changes to its incentive program for pharmaceutical and vaccines sales representatives, to be applied initially in the United...
    Eli Lilly gets USFDA nod for Cyramza to treat hepatocellular carcinoma

    Eli Lilly gets USFDA nod for Cyramza to treat hepatocellular carcinoma

    Medical Dialogues Bureau14 May 2019 9:47 AM IST
    The USFDA has removed the boxed warning from the CYRAMZA labelling which highlighted warnings pertaining to haemorrhage, gastrointestinal perforation...
    Ministry of AYUSH invites initial bids for strategic sale of IMPCL

    Ministry of AYUSH invites initial bids for strategic sale of IMPCL

    Garima18 April 2019 10:15 AM IST
    If the strategic sale of Indian Medicines Pharmaceutical Corporation Ltd (IMPCL), under the Ministry of AYUSH goes through the proceeds, would add to...
    Alchem solves stability dilemma for micronized DIGOXIN; files PATENT for novel production process

    Alchem solves stability dilemma for micronized DIGOXIN; files PATENT for novel production process

    Meghna A Singhania16 April 2019 4:47 PM IST
    Alchem's molecule is the sole micronized digoxin available globally that resolves the challenge of micro dosage formulation and the long-term...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok